Clinical Trial Update: A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma [Phase 2]

View source ↗

Summary

Phase 2 diagnostic study evaluating CD38-targeted ImmunoPET for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CD38-targeted ImmunoPET

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN